(Total Views: 596)
Posted On: 08/12/2020 8:45:59 PM
Post# of 148908
CT, just going off of what NP stated. He said more people and sicker people in order to reach stronger statistical significance. (all moderate, no mild; and I believe he threw out a number of 100 patients).
Not sure what you mean by running P3 with the same patients. Nor is that what NP stated.
Yes, it should enroll more quickly/easily. Is the severe trial enrolling quickly based on your discussion points? I don't think so. I would have thought based on the mild safety data we'd see a nice jump in severe enrollment as doctors realize the drug is extremely safe...but we haven't seen that.
Appreciate your commentary. You might want to re-listen to NP's comments!
I'm hoping severe's interim changes the conversation.
Not sure what you mean by running P3 with the same patients. Nor is that what NP stated.
Yes, it should enroll more quickly/easily. Is the severe trial enrolling quickly based on your discussion points? I don't think so. I would have thought based on the mild safety data we'd see a nice jump in severe enrollment as doctors realize the drug is extremely safe...but we haven't seen that.
Appreciate your commentary. You might want to re-listen to NP's comments!
I'm hoping severe's interim changes the conversation.
(1)
(0)Scroll down for more posts ▼
